Research/Industry Collaborations



We collaborate and create

To shape the future of transplant

mtak 2

We want to partner with brilliant scientists to advance transplant.  We need to develop the tools needed for better research. We are developing investigator initiated trials, helping build research consortia, running and expanding international registries. Listed below are a few of the projects we are working on right now. Check back often as we will be releasing details of additional new projects we are working on.


MTA Consortia

We have aligned with Mark Stegall, MD, at the Mayo Clinic to help make a new type of research consortium possible in organ transplantation. The MTA-K (kidney) and MTA-P (pancreas) are two major research consortia that we have already help build. These consortia are comprised of world class transplant centers. The MTA mission is to improve the outcomes of kidney and pancreas transplant recipients through innovative and efficient clinical trials conducting by leading medical institutions around the world. We believe new innovation will be possible through the MTA.

Find out more

International Intestinal Transplant Registry

We host the International Intestinal Transplant Registy (IITR). The mission of the IITR is to provide data on the outcomes of intestine transplantation to the international intestine transplant community in order to support their efforts and improve outcomes as well as inform policy development. We are also working with the Intestinal Rehabilitation and Transplant Association (ITRA) of the Transplantation Society to make the registry even better.  We hope we can learn and work together to make significant improvements in intestinal transplantation.

To access to the IITR Redcap portal

Clinical Trials

We are currently developing and facilitating single center and multicenter clinical trials in transplant. Here is a list of the current trials the Terasaki Research Institute is working on:

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients (DSA)

IVIg to Treat BK Viremia in Kidney Transplant Recipients

Envarsus XR® in Adolescent Renal Transplant Recipients (Envarsus XR)

Our Single Center Academic Collaborations

Collaboration is at the heart of all of our research. Since 2000, we have been actively working together academic partners to advance transplant. Here is a list of some of our more active collaborations:
  • Baylor University
  • Cedars Sinai Medical Center, Los Angeles, CA
  • Charité Universitätsmedizin Berlin
  • East Carolina University, Greenville, NC
  • Mayo Clinic, Rochester, MN
  • University of Michigan, Ann Arbor, MI
  • University of California, Los Angeles, Los Angeles, CA
  • Cornell University, New York, NY

To access to the Collaborations Redcap portal

Our Industry Partners

We are currently working together to advance the field of transplant with many industry partners through data research, core laboratory testing, and advising on clinical trials. Here is a list of the companies the Terasaki Research Institute partners with:
  • Astellas Pharma
  • BiologicTx
  • Bristol-Myers Squibb
  • CSL Behring
  • Immucor, Inc.
  • Octapharma AG
  • One Lambda, Inc
  • Veloxis Pharmaceutical


logo bottom